Pain Management, Plane Blocks, VATS
Conditions
Keywords
VATS, Pain Management, Plane Blocks, SPSIPB, SAPB
Brief summary
Comparison of the Analgesic Efficacy of Serratus Anterior Plane Block and Serratus Posterior Superior Intercostal Plane Block in Patients Undergoing Video-Assisted Thoracoscopic Surgery Introduction and Objective: The aim of this study is to compare the postoperative analgesic efficacy of the serratus anterior plane block and serratus posterior superior intercostal plane block performed under ultrasonography guidance in patients undergoing video-assisted thoracoscopic surgery. Patients with ASA grades I-III, aged 18-65, will be included in the study. Standard general anesthesia will be administered to the patients. Postoperative analgesia evaluation will be conducted using VAS and NRS scores at specific time points after surgery Additional analgesic requirements and patient satisfaction will be recorded.
Interventions
Ultrasound-guided serratus anterior plane block was performed at the 4th intercostal level in the mid-axillary line using an in plane technique. A total of 30 ml of %0.25 bupivacaine was injected into the fascial plane between the latissumus dorsi and serratus anterior muscles (unilateral)
PROCEDUREUltrasound guided serratus posterior superior intercostal plane block
Ultrasound-guided serratus posterior superior intercostal plane block was performed using an in plane technique. A total of 30 ml of %0.25 bupivacaine was injected into the fascial plane between the serratus posterior superior and intercostal muscles at the 3rd rib level via a posterior approach (unilateral)
Sponsors
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Patient aged between 18 and 65 years ASA physical status I-III Scheduled for elective video-assisted thoracoscopic surgery (VATS) Provided written information consent
Exclusion criteria
* History of allergy or toxicity to local anesthetic agents * Known or suspected coagulopathy * Infection at the site of block injection * Advanced organ failure * Diagnosed mental retardation * Pregnancy * Pediatric patients * History of thoracotomy * Requirement for postoperative intubation * Emergency surgery * Refusal to participate in the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative pain intensity | At postoperative 30 minute and 1, 4, 8, 12, 24 hours | Postoperative pain intensity was assessed using the Visual Analog Scale (VAS) where 0 indicates no pain and 10 indicates the worst imaginable pain |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative pain intensity assessed by Numeric Rating Scale (NRS) | 30 minutes, 1, 4, 8, 12, 24 hours after surgery | Postoperative pain intensity will be assessed using the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst pain imaginable) |
| Total 24-hour tramadol consumption | 24 hours after surgery | Total amount of rescue tramadol administered within the first 24 postoperative hours, recorded in milligrams |
| Rescue analgesia requirement | At postoperative 30 minute and 1, 4, 8, 12, 24 hours | Proportion of patients requiring rescue analgesia (intravenous tramadol) at each postoperative assessment time point |
| Adverse events | Within 24 hours after surgery | Incidence of local anesthetic systemic toxicity, pneumothorax, hypotension, nausea/vomiting, and block-related complications |
| Dynamic (movement-associated) postoperative pain intensity | At postoperative 30 minute and 1, 4, 8, 12, 24 hours | Postoperative pain intensity during movement/coughing was assessed using the Visual Analog Scale (VAS), distinct from the primary outcome which assessed pain at rest (static VAS) |
Countries
Turkey (Türkiye)
Outcome results
None listed